Showing results (1-10 of 190) with videos related to
Sort By:
Pageof 19
Stroke|March 1, 1993
Lupus anticoagulant and the fibrinolytic system in young patients with strokeD Ferro, C Quintarelli, M Rasura, et al.Thrombosis Research|August 1, 1990
Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosusD Ferro, M Saliola, C Quintarelli, et al.European Journal of Clinical Pharmacology|January 1, 1992
Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balanceF Violi, D Ferro, M Saliola, et al.Digestive Diseases (Basel, Switzerland)|January 1, 1992
Clotting abnormalities in chronic liver diseaseF Violi, D Ferro, C Quintarelli, et al.Journal of Hepatology|December 1, 1994
Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levelsC Quintarelli, D Ferro, G Valesini, et al.Seminars in Thrombosis and Hemostasis|April 1, 1989
Inhibition of tissue plasminogen activator inhibitor by defibrotide in atherosclerotic patientsF Violi, D Ferro, C Alessandri, et al.Gastroenterology|August 1, 1995
Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosisF Violi, D Ferro, S Basili, et al.Hepatology (Baltimore, Md.)|January 1, 1993
Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver CirrhosisF Violi, D Ferro, S Basili, et al.Thrombosis and Haemostasis|April 12, 1990
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosisF Violi, D Ferro, C Quintarelli, et al.Hepatology (Baltimore, Md.)|June 1, 1996
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemiaD Ferro, C Quintarelli, A Lattuada, et al.Pageof 19